Circulating cellular adhesion molecules and risk of diabetes: the Multi‐Ethnic Study of Atherosclerosis (MESA)
暂无分享,去创建一个
J. Pankow | S. Bielinski | N. Larson | P. Decker | A. Kanaya | M. Sale | Weihong Tang | C. Wassel | M. Tsai | N. Hanson | S. Bielinski | W. Tang | M. Tsai | C. Berardi | M. Sale | P. Decker | C. Berardi | C. L. Wassel | Weihong Tang | Michael Y. Tsai | Naomi Q. Hanson | Paul A. Decker | James S. Pankow | Nicholas B. Larson | Michael Y. Tsai | Paul A Decker
[1] J. Pankow,et al. P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2015, Atherosclerosis.
[2] J. Pankow,et al. Multi-ethnic analysis reveals soluble l-selectin may be post-transcriptionally regulated by 3′UTR polymorphism: the Multi-Ethnic Study of Atherosclerosis (MESA) , 2015, Human Genetics.
[3] J. Pankow,et al. Plasma and serum L-selectin and clinical and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2014, Translational research : the journal of laboratory and clinical medicine.
[4] M. Telen. Cellular adhesion and the endothelium: E-selectin, L-selectin, and pan-selectin inhibitors. , 2014, Hematology/oncology clinics of North America.
[5] S. Hua. Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies , 2013, Front. Pharmacol..
[6] C. Stehouwer,et al. Microvascular Dysfunction Is Associated With a Higher Incidence of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[7] E. Benjamin,et al. Addition of Inflammatory Biomarkers Did Not Improve Diabetes Prediction in the Community: The Framingham Heart Study , 2012, Journal of the American Heart Association.
[8] M. Day,et al. Soluble E-cadherin: more than a symptom of disease. , 2012, Frontiers in bioscience.
[9] R. Adamiec,et al. [Serum level of sL-selectin and leukocyte surface expression of L-selectin in patients with type 2 diabetes]. , 2011, Przeglad lekarski.
[10] Gang Liu,et al. Identification of urinary soluble E‐cadherin as a novel biomarker for diabetic nephropathy , 2009, Diabetes/metabolism research and reviews.
[11] P. Macfarlane,et al. Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly , 2009, Diabetologia.
[12] J. Pankow,et al. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). , 2008, Atherosclerosis.
[13] R. Muniyappa,et al. An integrated view of insulin resistance and endothelial dysfunction. , 2008, Endocrinology and metabolism clinics of North America.
[14] M. Trevisan,et al. Additional Contribution of Emerging Risk Factors to the Prediction of the Risk of Type 2 Diabetes: Evidence From the Western New York Study , 2008, Obesity.
[15] J. Manson,et al. Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women , 2007, Diabetes.
[16] J. Pankow,et al. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study , 2006, Diabetologia.
[17] V. Mohan,et al. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study. , 2006, Metabolism: clinical and experimental.
[18] Barbara Thorand,et al. Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[19] K. Lohman,et al. Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. , 2004, Clinical chemistry.
[20] J. Manson,et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. , 2004, JAMA.
[21] T. Funahashi,et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. , 2003, Diabetes care.
[22] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[23] Klaus Ley,et al. L-Selectin Shedding Regulates Leukocyte Recruitment , 2001, The Journal of experimental medicine.
[24] O. Tikhomirov,et al. Production of soluble P-selectin by platelets and endothelial cells. , 1999, Biochemistry. Biokhimiia.
[25] K. Nakagawa,et al. Soluble E-cadherin fragments increased in circulation of cancer patients. , 1994, British Journal of Cancer.
[26] S. J. Cashman,et al. Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance , 1992, Annals of the New York Academy of Sciences.
[27] H. Wolinsky. Circulation Research an Official Journal of the American Heart Association a Proposal Linking Clearance of Circulating Lipoproteins to Tissue Metabolic Activity as a Basis for Understanding Atherogenesis , 2022 .